Laparoscopic complete mesocolic excision after neoadjuvant immunotherapy for advanced microsatellite instability high/deficient mismatch repair transverse colon cancer – a video vignette

Colorectal DiseaseEarly View VIDEO CORRESPONDENCE Laparoscopic complete mesocolic excision after neoadjuvant immunotherapy for advanced microsatellite instability high/deficient mismatch repair transverse colon cancer – a video vignette Yugui Lian, Corresponding Author Yugui Lian [email protected] Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Correspondence Yugui Lian, Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Email: [email protected] Contribution: Visualization, Conceptualization, Supervision, Validation, Resources, Writing - review & editingSearch for more papers by this authorXiaofei Duan, Xiaofei Duan Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Software, Writing - original draft, VisualizationSearch for more papers by this authorShengyun Hu, Shengyun Hu Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Software, VisualizationSearch for more papers by this authorMingyu Han, Mingyu Han Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Visualization, Software, Data curationSearch for more papers by this authorWeitang Yuan, Weitang Yuan Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Supervision, Resources, ConceptualizationSearch for more papers by this author Yugui Lian, Corresponding Author Yugui Lian [email protected] Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Correspondence Yugui Lian, Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Email: [email protected] Contribution: Visualization, Conceptualization, Supervision, Validation, Resources, Writing - review & editingSearch for more papers by this authorXiaofei Duan, Xiaofei Duan Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Software, Writing - original draft, VisualizationSearch for more papers by this authorShengyun Hu, Shengyun Hu Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Software, VisualizationSearch for more papers by this authorMingyu Han, Mingyu Han Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Visualization, Software, Data curationSearch for more papers by this authorWeitang Yuan, Weitang Yuan Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zheng zhou, China Contribution: Supervision, Resources, ConceptualizationSearch for more papers by this author First published: 29 March 2024 https://doi.org/10.1111/codi.16965Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Lenz HJ, Van Cutsem E, Luisa Limon M, Wong KYM, Hendlisz A, Aglietta M, et al. First-line nivolumab plus low-dose ipilimumab for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. J Clin Oncol. 2022; 40: 161–170. 10.1200/JCO.21.01015 CASPubMedWeb of Science®Google Scholar 2Verschoor YL, vanden Berg JG, Beets G, Sikorska K, Aalbers A, van Lent AV, et al. Neoadjuvant nivolumab, ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: final clinical analysis of the NICHE study. J Clin Oncol. 2022; 40: 3511. 10.1200/JCO.2022.40.16_suppl.3511 Web of Science®Google Scholar 3Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, et al. PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022; 386: 2363–2376. 10.1056/NEJMoa2201445 CASPubMedWeb of Science®Google Scholar 4Neola B, Vanella S, Noviello A, Crafa F. Splenic flexure mobilization: our medial-to-lateral approach – a video vignette. Colorectal Dis. 2021; 23: 2490. 10.1111/codi.15774 PubMedWeb of Science®Google Scholar 5Snider J, Gay R, Caycedo-Marulanda A. The laparoscopic medial-to-lateral approach to the splenic flexure. Tech Coloproctol. 2019; 23: 781–782. 10.1007/s10151-019-02018-6 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation